Stem Cell LSB inhibitor Set
Axon 5004
CAS [N.A.]
MF #N/AMW #N/A
- Purity:99%
- Soluble in DMSO
Description
A convenient set of BMP inhibitor LDN 193189 hydrochloride (Axon 1509) and TGF-β inhibitor SB 431542 (Axon 1661) (termed as LSB by their name abbreviation), for neural differentiation of human pluripotent stem cells (hPSCs). Dual SMAD inhibition by LSB cocktail is an highly efficient protocol for neural induction of hPSCs and more than 80% of hPSCs can be rapidly induced into Pax6+ neural precursor cells by using LDN 193189 (0.1 µM) and SB 431542 (10 µM).
LSB protocol can be further extended; with adding CHIR 99021 (Axon 1386) to form LSC or LSB/CHIR inhibitor set (Axon 5005) for generating subtype specific neural/neuronal cells; or with combining neuronal 3i (CSD) inhibitor set (Axon 5006) of CHIR 99021 (Axon 1386), SU 5402 (Axon 1667) and DAPT (Axon 1484) to form a 5i inhibitor set (Axon 5007, LSB3i), for rapid differentiation of hPSCs into nociceptors.
Read more: Additional Product Information
Show all Axon Ligand™Sets
J. Ladewig et al. Small molecules enable highly efficient neuronal conversion of human fibroblasts. Nat Methods. 2012, 9, 575-578. |
S.M. Chambers et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nature Biotechnol. 2012, 30, 715-720. |
S.M. Chambers et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27, 275–280. |
List of publications using LDN 193189 hydrochloride(Axon 1509) purchased from Axon Medchem
- Certificate of Analysis
- Material Safety Data Sheet
- Additional Product Information
Chemical name
N.A.
Parent CAS No.
[N.A.]